The AKV murine leukemia virus is restricted and hypermutated by mouse APOBEC3

Journal of Virology

Volumn 83, Issue 22, 2009, Pages 11550-11559

  Langlois, Marc André ^a,b   Kemmerich, Kristin ^a   Rada, Cristina ^a   Neuberger, Michael S ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; ISOPROTEIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA POLYMORPHISM; EX VIVO STUDY; GENE DISRUPTION; GENE SEQUENCE; GENETIC TRANSFECTION; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE ANALYSIS; THYMUS LYMPHOMA; VIROGENESIS; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

3T3 CELLS; ANIMALS; CYTIDINE DEAMINASE; LEUKEMIA VIRUS, MURINE; LEUKEMIA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RATS; RETROVIRIDAE INFECTIONS; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, PROTEIN; TUMOR VIRUS INFECTIONS;

AKV MURINE LEUKEMIA VIRUS; MURINAE; MUS; PRIMATES; RODENTIA;

EID: 70350312835     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01430-09     Document Type: Article

References (61)

1. Aagaard, L., J. G. Mikkelsen, S. Warming, M. Duch, and F. S. Pedersen. 2002. Fv1-like restriction of N-tropic replication-competent murine leukaemia viruses in mCAT-1-expressing human cells. J. Gen. Virol. 83:439-442.
2. Abudu, A., A. Takaori-Kondo, T. Izumi, K. Shirakawa, M. Kobayashi, A. Sasada, K. Fukunaga, and T. Uchiyama. 2006. Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms. Curr. Biol. 16:1565-1570.
3. Bachrach, E., M. Pelegrin, M. Piechaczyk, F. S. Pedersen, and M. Duch. 2002. Efficient gene transfer into spleen cells of newborn mice by a replication- competent retroviral vector. Virology 293:328-334. (Pubitemid 34928854)
4. Beale, R. C., S. K. Petersen-Mahrt, I. N. Watt, R. S. Harris, C. Rada, and M. S. Neuberger. 2004. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J. Mol. Biol. 337:585-596.
5. Bedigian, H. G., N. G. Copeland, N. A. Jenkins, K. Salvatore, and S. Rodick. 1983. Emv-13 (Akv-3): a noninducible endogenous ecotropic provirus of AKR/J. mice. J. Virol. 46:490-497.
6. Best, S., P. Le Tissier, G. Towers, and J. P. Stoye. 1996. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 382:826-829. (Pubitemid 26299569)
7. Bieniasz, P. D. 2004. Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol. 5:1109-1115.
8. Bishop, K. N., R. K. Holmes, and M. H. Malim. 2006. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J. Virol. 80:8450-8458.
9. Bishop, K. N., R. K. Holmes, A. M. Sheehy, N. O. Davidson, S. J. Cho, and M. H. Malim. 2004. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14:1392-1396.
10. Bishop, K. N., M. Verma, E. Y. Kim, S. M. Wolinsky, and M. H. Malim. 2008. APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog. 4:e1000231.
11. Bogerd, H. P., B. P. Doehle, H. L. Wiegand, and B. R. Cullen. 2004. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl. Acad. Sci. USA 101:3770-3774.
12. - mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J. Virol. 69: 2058-2067.
13. Brightman, B. K., M. Okimoto, V. Kulkarni, J. K. Lander, and H. Fan. 1998. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice. Virology 242:60-67.
14. Browne, E. P., and D. R. Littman. 2008. Species-specific restriction of APOBEC3-mediated hypermutation. J. Virol. 82:1305-1313.
15. Chattopadhyay, S. K., W. P. Rowe, N. M. Teich, and D. R. Lowy. 1975. Definitive evidence that the murine C-type virus inducing locus Akv-1 is viral genetic material. Proc. Natl. Acad. Sci. USA 72:906-910.
16. Chelico, L., P. Pham, P. Calabrese, and M. F. Goodman. 2006. APOBEC3G DNA deaminase acts processively 3′→5′ on single-stranded DNA. Nat. Struct. Mol. Biol. 13:392-399.
17. Chiu, Y. L., and W. C. Greene. 2008. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26:317-353.
18. + T cells. Nature 435:108-114.
19. Cloyd, M. W., J. W. Hartley, and W. P. Rowe. 1980. Lymphomagenicity of recombinant mink cell focus-inducing murine leukemia viruses. J. Exp. Med. 151:542-552.
20. Conticello, S. G., R. S. Harris, and M. S. Neuberger. 2003. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol. 13:2009-2013.
21. Doehle, B. P., A. Schafer, H. L. Wiegand, H. P. Bogerd, and B. R. Cullen. 2005. Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion. J. Virol. 79:8201-8207.
22. Esnault, C., O. Heidmann, F. Delebecque, M. Dewannieux, D. Ribet, A. J. Hance, T. Heidmann, and O. Schwartz. 2005. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature 433:430-433. (Pubitemid 40203324)
23. Esnault, C., J. Millet, O. Schwartz, and T. Heidmann. 2006. Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses. Nucleic Acids Res. 34:1522-1531.
24. Hartley, J. W., and W. P. Rowe. 1975. Clonal cell lines from a feral mouse embryo which lack host-range restrictions for murine leukemia viruses. Virology 65:128-134.
25. Ikeda, H., and T. Odaka. 1983. Cellular expression of murine leukemia virus gp70-related antigen on thymocytes of uninfected mice correlates with Fv-4 gene-controlled resistance to Friend leukemia virus infection. Virology 128: 127-139.
26. + T cells. J. Virol. 75:7973-7986.
27. Jenkins, N. A., N. G. Copeland, B. A. Taylor, and B. K. Lee. 1982. Organization, distribution, and stability of endogenous ecotropic murine leukemia virus DNA sequences in chromosomes of Mus musculus. J. Virol. 43:26-36.
28. Jern, P., J. P. Stoye, and J. M. Coffin. 2007. Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genet. 3:2014-2022. (Pubitemid 350072064)
29. Kobayashi, M., A. Takaori-Kondo, K. Shindo, A. Abudu, K. Fukunaga, and T. Uchiyama. 2004. APOBEC3G targets specific virus species. J. Virol. 78:8238-8244. (Pubitemid 38944307)
30. Kozak, C. A. 1985. Analysis of wild-derived mice for Fv-1 and Fv-2 murine leukemia virus restriction loci: a novel wild mouse Fv-1 allele responsible for lack of host range restriction. J. Virol. 55:281-285.
31. Kubo, Y., A. Ishimoto, T. Ono, H. Yoshii, C. Tominaga, C. Mitani, H. Amanuma, and N. Yamamoto. 2004. Determinant for the inhibition of ecotropic murine leukemia virus infection by N-linked glycosylation of the rat receptor. Virology 330:82-91. (Pubitemid 39446569)
32. Langlois, M. A., R. C. Beale, S. G. Conticello, and M. S. Neuberger. 2005. Mutational comparison of the single-domained APOBEC3C and doubledomained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities. Nucleic Acids Res. 33:1913-1923.
33. Lovmand, J., A. B. Sorensen, J. Schmidt, M. Ostergaard, A. Luz, and F. S. Pedersen. 1998. B-cell lymphoma induction by AKV murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer. J. Virol. 72:5745-5756. (Pubitemid 28283359)
34. Low, A., C. M. Okeoma, N. Lovsin, M. de Las Heras, T. H. Taylor, B. M. Peterlin, S. R. Ross, and H. Fan. 2009. Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene. Virology 385:455-463.
35. Mangeat, B., P. Turelli, S. Liao, and D. Trono. 2004. A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action. J. Biol. Chem. 279:14481-14483.
36. Mariani, R., D. Chen, B. Schrofelbauer, F. Navarro, R. Konig, B. Bollman, C. Munk, H. Nymark-McMahon, and N. R. Landau. 2003. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114:21-31. (Pubitemid 36859838)
37. Marin, M., K. M. Rose, S. L. Kozak, and D. Kabat. 2003. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9:1398-1403.
38. Mikl, M. C., I. N. Watt, M. Lu, W. Reik, S. L. Davies, M. S. Neuberger, and C. Rada. 2005. Mice deficient in APOBEC2 and APOBEC3. Mol. Cell. Biol. 25:7270-7277.
39. Newman, E. N., R. K. Holmes, H. M. Craig, K. C. Klein, J. R. Lingappa, M. H. Malim, and A. M. Sheehy. 2005. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol. 15:166-170.
40. Okeoma, C. M., N. Lovsin, B. M. Peterlin, and S. R. Ross. 2007. APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 445:927-930. (Pubitemid 46309832)
41. Okeoma, C. M., J. Petersen, and S. R. Ross. 2009. Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection. J. Virol. 83:3029-3038.
42. Perez-Caballero, D., S. J. Soll, and P. D. Bieniasz. 2008. Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5α proteins. PLoS Pathog. 4:e1000181.
43. Petit, V., D. Guetard, M. Renard, A. Keriel, M. Sitbon, S. Wain-Hobson, and J. P. Vartanian. 2009. Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. J. Mol. Biol. 385:65-78.
44. Rowe, W. P., J. W. Hartley, and T. Bremner. 1972. Genetic mapping of a murine leukemia virus-inducing locus of AKR mice. Science 178:860-862.
45. Rowe, W. P., and C. A. Kozak. 1980. Germ-line reinsertions of AKR murine leukemia virus genomes in Akv-1 congenic mice. Proc. Natl. Acad. Sci. USA 77:4871-4874.
46. Rulli, S. J., Jr., J. Mirro, S. A. Hill, P. Lloyd, R. J. Gorelick, J. M. Coffin, D. Derse, and A. Rein. 2008. Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses. J. Virol. 82:6566-6575.
47. Santiago, M. L., M. Montano, R. Benitez, R. J. Messer, W. Yonemoto, B. Chesebro, K. J. Hasenkrug, and W. C. Greene. 2008. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 321:1343-1346.
48. Sawyer, S. L., M. Emerman, and H. S. Malik. 2004. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2:E275.
49. Schröfelbauer, B., D. Chen, and N. R. Landau. 2004. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc. Natl. Acad. Sci. USA 101:3927-3932.
50. Sheehy, A. M., N. C. Gaddis, J. D. Choi, and M. H. Malim. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
51. Sheehy, A. M., N. C. Gaddis, and M. H. Malim. 2003. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9:1404-1407.
52. Sliva, K., O. Erlwein, A. Bittner, and B. S. Schnierle. 2004. Murine leukemia virus (MLV) replication monitored with fluorescent proteins. Virol. J. 1:14. (Pubitemid 40412658)
53. Stoye, J. P., C. Moroni, and J. M. Coffin. 1991. Virological events leading to spontaneous AKR thymomas. J. Virol. 65:1273-1285.
54. Suspène, R., P. Sommer, M. Henry, S. Ferris, D. Guetard, S. Pochet, A. Chester, N. Navaratnam, S. Wain-Hobson, and J. P. Vartanian. 2004. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Res. 32:2421-2429.
55. Takeda, E., S. Tsuji-Kawahara, M. Sakamoto, M. A. Langlois, M. S. Neuberger, C. Rada, and M. Miyazawa. 2008. Mouse APOBEC3 restricts Friend leukemia virus infection and pathogenesis in vivo. J. Virol. 82:10998-11008.
56. Vartanian, J. P., M. Henry, and S. Wain-Hobson. 2002. Sustained G3A hypermutation during reverse transcription of an entire human immunode- ficiency virus type 1 strain Vau group O genome. J. Gen. Virol. 83:801-805.
57. Vartanian, J. P., A. Meyerhans, B. Asjo, and S. Wain-Hobson. 1991. Selection, recombination, and G3A hypermutation of human immunodeficiency virus type 1 genomes. J. Virol. 65:1779-1788.
58. Wang, H., M. P. Kavanaugh, R. A. North, and D. Kabat. 1991. Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature 352:729-731. (Pubitemid 21912418)
59. Yu, X., Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X. F. Yu. 2003. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302:1056-1060.
60. Zhang, J., and D. M. Webb. 2004. Rapid evolution of primate antiviral enzyme APOBEC3G. Hum. Mol. Genet. 13:1785-1791.
61. Zhang, L., X. Li, J. Ma, L. Yu, J. Jiang, and S. Cen. 2008. The incorporation of APOBEC3 proteins into murine leukemia viruses. Virology 378:69-78.